Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-17-004518
Filing Date
2017-12-08
Accepted
2017-12-08 13:52:56
Documents
1

Document Format Files

Seq Description Document Type Size
1 TRILLIUM THERAPEUTICS INC. p17-2299sc13g.htm SC 13G 66800
  Complete submission text file 0000902664-17-004518.txt   68443
Mailing Address 1000 WINTER STREET C/O MATRIX CAPITAL MANAGEMENT WALTHAM MA 02451
Business Address 1000 WINTER STREET C/O MATRIX CAPITAL MANAGEMENT WALTHAM MA 02451 781-522-4948
Matrix Capital Management Company, LP (Filed by) CIK: 0001410830 (see all company filings)

EIN.: 043475951 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9
Business Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9 (416) 595-0627
Trillium Therapeutics Inc. (Subject) CIK: 0001616212 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1214
Type: SC 13G | Act: 34 | File No.: 005-88719 | Film No.: 171246771
SIC: 2834 Pharmaceutical Preparations